ALS (Amyotrophic Lateral Sclerosis), Duchenne Muscular Dystrophy (DMD), MSA - Multiple System Atrophy, Neuromuscular Diseases (NMD), SMA - Spinal Muscular Atrophy, Spinal Cord Injuries (SCI), Tracheostomized Patients, Tracheostomy
Conditions
Brief summary
The aim of this study is to describe national trends over the past 10 years in patients receiving invasive home mechanical ventilation (HMV) in Denmark. This includes indications for invasive HMV, diagnostic groups, and one-year mortality.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients are included if they have or have had a respiratory certified personale care assistent during the period 2016-2025.
Exclusion criteria
* Not tracheostomized * Tracheostomized but on spontaneous breathing throughout 1 January 2016 - 31 December 2025 * Not discharged to home, assisted living, nursing home, or rehabilitation during 1 January 2016 - 31 December 2025
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of patients with invasive home mechanical ventilation | Each year during the periode from 01.01.2016 to 12.31.2025 | Incidence of patients with invasive home mechanical ventilation per year per 100,000 population |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of patients on home mechanical ventilation pr. year | Each year during the periode from 01.01.2016 to 12.31.2025 | — |
| Number of new patients on invasive home mechanical ventilation per year | Each year during the periode from 01.01.2016 to 12.31.2025 | The absolute number of patients starting on invasive home mechanical ventilation each year. |
| One-year mortality | Periode from 01.01.2016 to 12.31.2025 | 1-year mortality after initiation of invasive home mechanical ventilation |
Countries
Denmark